Instructions for Authors
Online Manuscript Submission: An online submission
and tracking service via internet facilitates a speedy and
cost-effective submission of manuscripts. The full manuscript
should be submitted online via Bentham's Content
Management System (CMS) at www.bentham-editorial.org
(View
Submission Instructions). Alternatively, you
may submit the full paper to patents@benthamscience.org
Manuscripts must be submitted by one of the
authors of the manuscript, and should not be submitted by
anyone on their behalf. The principal / corresponding author
will be required to submit a Cover Letter along with the manuscript,
on behalf of all the co-authors (if any) to confirm that the
manuscript (or any part of it) has not been published previously
or is not under consideration for publication elsewhere. Furthermore,
any illustration, structure or table that has been published
elsewhere must be reported, and copyright permission for reproduction
must be obtained. The figures from patent documents are freely
available on the databases and may not require any permission
unless stated otherwise.
For all online submissions, please provide soft copies of all the materials (main text in MS Word or Tex/LaTeX), figures / illustrations in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw (CDX) / ISISDraw (TGF) as separate files, while a PDF version of the entire manuscript must also be included, embedded with all the figures / illustrations / tables / chemical structures etc. It is advisable that the document files related to a manuscript submission should always have the name of the corresponding author as part of the file name, i.e., “Cilli MS text.doc”, “Cilli MS Figure 1”, etc.
It is imperative that before submission,
the author(s) should carefully proofread the files for special
characters, mathematical symbols, Greek letters, equations,
tables, references and images to ensure that they appear in
proper format.
References, figures, tables, chemical structures,
etc. should be referred to in the text at the appropriate
places where they have been first discussed. Figure legends
/ captions should also be provided.
A successful electronic submission of the
manuscript will be confirmed by a system-generated email acknowledgement
to the principal/corresponding author immediately. Any queries
therein should be addressed to patents@benthamscience.org
MANUSCRIPTS PUBLISHED: The
journal publishes peer-reviewed mini- and full-length review
and research articles written in English. Single Topic/Thematic
Issues edited by invited Guest Editors are also considered
for publication.
For the submission of research articles, the author should
have already filed a patent with a leading patent authority
and it should be registered. Secondly, the author should not
have published any research paper on the intellectual property
of that patent.
Single Topic Issues: These special issues are peer-reviewed and may contain invited or uninvited review/mini-review articles or a mixture of research articles and reviews/ mini-reviews. A Single Topic Issue Editor will offer a short perspective and co-ordinate the solicitation of manuscripts between 3-5 (for a mini-hot topic) to 6-10 (for full-length hot topic) from leading scientists. Authors interested in editing a single topic issue in an emerging topic of anti-cancer drug discovery may submit their proposal to the Editor-in-Chief at patents@benthamscience.org or pra@benthamscience.org for consideration.
Patent Selections:
A separate section of important and recent patents on anti-cancer
drug discovery is also included in the journal. The patents
annotated in this section are relevant to the articles published
in this journal issue, categorized by therapeutic areas/targets
and therapeutic agents related to anti-cancer drug discovery.
MANUSCRIPT LENGTH:
Research Articles: Research articles should
be 4000-8000 words excluding figures, structures, photographs,
schemes, tables etc.
Mini-Reviews: Mini-reviews should be 3000-6000
words excluding figures, structures, photographs, schemes,
tables etc.
Full-Length Reviews: Full-length reviews
should be 8000-40000 words excluding figures, structures,
photographs, schemes, tables etc.
MANUSCRIPT PREPARATION: The manuscript should
be written in English in a clear, direct and active style.
All pages must be numbered sequentially, facilitating in the
reviewing and editing of the manuscript. For further convenience,
the customer support team available at Bentham
Publishing Services (www.benthampublishingservices.com)
can provide assistance to authors for the preparation of manuscripts.
MANUSCRIPT SECTIONS FOR PAPERS:
Manuscripts may be divided into the following sections:
1. Cover Letter: It is mandatory to submit
a signed covering letter along with the manuscript, by the
author to whom correspondence is to be addressed, delineating
the scope of the submitted article declaring the potential
competing interests, acknowledging contributions from authors
and funding agencies, and certifying that the paper is prepared
according to the 'Instructions for Authors'.
All inconsistencies in the text and in the reference section
and any typographical errors must be carefully checked and
corrected before the submission of the manuscript. The article
should not contain any material or information that may be
unlawful, defamatory, fabricated, plagiarized, or which would,
if published, in any way whatsoever, violate the terms and
conditions as laid down in the copyright agreement. The authors
should acknowledge that the publishers have the legal right
to take appropriate action against the authors for any such
violation of the terms and conditions as laid down in the
copyright agreement. To download the cover letter, please
visit: www.benthamscience.com/pra/Covering-Letter.doc
2. Title: The title of the article should
be precise and brief and must not be more than 120 characters.
Authors should avoid the use of non-standard abbreviations.
The title must be written in title case except for articles,
conjunctions and prepositions.
3. Short Running Title: Authors must provide
a short ‘running title’ of their manuscripts.
4. Authors’ Names and Affiliations:
The names of the authors should be provided according to the
previous citations or as the authors would want them to be
published along with the institutional affiliations, current
address, telephone, cell & fax numbers and the email address.
Email address must be provided with an asterisk in front of
the name of the principal author. The corresponding author
should also be designated and the full address, telephone,
cell & fax numbers and the email address must be stated
to receive correspondence and galley proofs.
5. Abstract: The abstract summarizing the
essential features of the review or research article should
not exceed 200 words and must include information regarding
patents.
6. Keywords: Authors must provide 6 to 8
keywords in alphabetical order.
7. Text Organization: The main text should
begin on a separate page and should be divided into title
page, abstract and the main text. The text may be subdivided
further according to the areas to be discussed, which should
be followed by the Acknowledgement (if any) and Reference
sections. The Review Article should mention any previous important,
recent and old reviews in the field and contain a comprehensive
discussion starting with the general background of the field.
It should then go on to discuss the salient features of recent
developments along with relevant patents. The authors should
avoid presenting material which has already been published
in a previous review. The authors are advised to present and
discuss their observations in brief. For Research Articles,
the manuscript should begin with the title page and abstract
followed by the main text, which must be structured into separate
sections as Introduction, Material and Methods, Results, Discussion,
Conclusion, Current & Future Developments, Acknowledgements,
Conflict of Interest and References. The patent registration
number and patent authority of the author's intellectual property
must be cited in the article. The manuscript style must be
uniform throughout the text and 10pt Times New Roman font
should be used. The full term for an abbreviation should precede
its first appearance in the text unless it is a standard unit
of measurement. Italics should be used for Binomial names
of organisms (Genus and Species) for emphasis and for unfamiliar
words or phrases. Non-assimilated words from Latin or other
languages should also be italicized e.g. per se, et al.,
in vitro, in vivo, in situ, etc.
Authentication of Cell Lines: The
NIH acknowledges the misidentification and/or cross-contamination
of cell cultures e.g. HeLa cells being used in a research
study as a serious problem. In order to ensure the validation
of the work and proper utilization of resources, it is a prerequisite
that correct reagents be used in studies dealing with established
human (tumor) cell lines that have been cultured for more
than 4 years up to the date of submission of the manuscript.
Cell lines such as short-term cultures of human tumors, murine
cell lines (as a catalog of DNA profiles is not yet available)
and tumor cell lines established in the course of the study
that is being submitted, are presently exempt from this rule.
To minimize the risk of working with misidentified and/or
contaminated cell lines, tests such as isoenzyme analysis,
karyotyping/cytogenetic analysis and, more recently, molecular
techniques of DNA profiling may be carried out to authenticate
cell cultures. These tests may help confirm or establish the
identify profile for a cell line. Bentham Science recommends
that all cell lines be authenticated prior to submitting a
paper for review. Authors are therefore required to provide
authentication of the origin and identity of the cells by
performing cell profiling either in their own laboratory or
by outsourcing an approved laboratory or cell bank. Authentication
is required when a new line is established or acquired, before
freezing a cell line, if the performance of the line is not
consistent or results are unexpected, if using more than one
cell line, and before publication of the study.
The cell lines profile should be cross-checked with the profile
of the donor tissue of other continuous cell lines such as
provided by the authentic data bank such as http://www.dsmz.de/fp/cgi-bin/str.html,
ATCC® etc.
Standard Protocol on Approvals, Registrations,
Patient Consents & Animal Protection: All
clinical investigations must be conducted according to the
Declaration of Helsinki principles. Authors must comply with
the guidelines of the International Committee of Medical Journal
Editors (http://www.icmje.org)
with regard to the patient’s consent for research or
participation in a study. Patients' names, initials, or hospital
numbers must not be mentioned anywhere in the manuscript (including
figures). Editors may request that authors provide documentation
of the formal review and recommendation from the institutional
review board or ethics committee responsible for oversight
of the study.
In addition to the standard patient consent for participation
in research, authors are responsible for obtaining patient
consent-to-disclose forms for all recognizable patients in
photographs, videos, or other information that may be published
in the Journal, in derivative works, or on the journal’s
website and providing the manuscript to the recognizable patient
for review before submission. The consent-to-disclose form
should indicate specific use (publication in the medical literature
in print and online, with the understanding that patients
and the public will have access) of the patient's information
and any images in figures or videos, and must contain the
patient's signature or that of a legal guardian along with
a statement that the patient or legal guardian has been offered
the opportunity to review the identifying materials and the
accompanying manuscript.
For research involving animals, the authors should indicate
whether the procedures followed were in accordance with the
standards set forth in the Guide for the Care and Use of Laboratory
Animals (published by the National Academy of Science, National
Academy Press, Washington, D.C.).
A specific declaration of such approval and consent-to-disclose
form must be made in the cover letter and in a stand-alone
paragraph at the end of the Methods section especially in
the case of human studies where inclusion of a statement regarding
obtaining the written informed consent from each subject or
subject's guardian is a must. The original should be retained
by the guarantor or corresponding author. Editors may request
to provide the original forms by fax or email.
Patent Review Coverage: Authors
should review the most recent and important patents based
on the topic covered. Coverage of novel bioactive compounds,
analogs & targets, techniques and drug design in all areas
of anti-cancer drug discovery should be emphasized, including
the significance of reported patents.
Current & Future Developments:
The review / research article should conclude with a short
section called “Current & Future Developments”.
The author(s) will give their opinion on the current and future
important developments on the topic discussed in their article.
Symbols and Units: Greek symbols
and special characters often undergo formatting changes and
get corrupted or lost during preparation of a manuscript for
publication. To ensure that all special characters used are
embedded in the text, these special characters should be inserted
as a symbol but should not be a result of any format styling
(Symbol font face) otherwise they will be lost during the
conversion to PDF / XML.
Authors are encouraged to consult reporting guidelines. These
guidelines provide a set of recommendations comprising a list
of items relevant to their specific research design.
Only ISO symbols, written in italic, should be used for the
various parameters. All kinds of measurements should be reported
only in International System of Units (SI). SI units should
always be written in Roman and separated from the numerical
value by a space (whatever the language).
The µ in µg or µm should be in Roman. The
symbol for litre is L and that for minute is min. For temperature,
please use only one of °C, °F or K in the entire manuscript.
As the Angström (1Å = 10-10
m) is not an SI unit, it should be replaced by the nanometre
(1nm = 10-9 m) or by the
picometer (1pm = 10-12 m):
1Å = 0.1nm = 100pm. Multiple units should be written
with negative superscripts (for example, 25mgµL-1
µs-1). The list of
notations should appear just before the first paragraph of
full text.
A list of symbols and units should be provided if used extensively
throughout the text.
8. List of Abbreviations: If abbreviations
are used in the text either they should be defined in the
text where first used, or a list of abbreviations can be provided.
9. Acknowledgements: The specific requirements
for authorship have been defined by the International Committee
of Medical Journal Editors (ICMJE; http://www.icmje.org).
Examples of authors' contributions are: 'designed research/study',
'performed research/study', 'contributed important reagents',
'collected data', 'analyzed data', 'wrote paper' etc. This
information must be included in the submitted manuscript as
a separate paragraph under the heading ‘Acknowledgements’.
The corresponding author is responsible for obtaining permission
from all co-authors for the submission of any version of the
manuscript and for any changes in the authorship.
All individuals listed as authors must have contributed substantially
to the design, performance, analysis, or reporting of the
work and are required to indicate their specific contribution.
Anyone (individual/company/institution) who has substantially
contributed to the study for important intellectual content,
or who was involved in the article’s drafting the manuscript
or revising must also be acknowledged.
Guest or honorary authorship based solely on position (e.g.
research supervisor, departmental head) is discouraged.
10. Conflict of Interest: Financial contributions
to the work being reported must be clearly acknowledged, as
should any potential conflict of interest under the heading
‘Conflict of Interest’. Authors
must list the source(s) of funding for the study, for each
author, and for the manuscript preparation. No patents should
be cited by authors that are in various stages of legal litigation.
11. References: References should be numbered
sequentially [in square brackets] in the text and listed in
the same numerical order in the reference section. All references
must be complete and accurate. Online citations should include
the date of access. Journal titles should conform to the present
Index Medicus abbreviations. It is necessary to list all authors
if the total number of authors is 6 or less and for more than
6 authors use 6 authors and then et al. The reference
numbers must be finalized and the bibliography must be fully
formatted before submission.
References should be listed in the following
Vancouver Style:
Journal:
[1] Choi M-J, Jung KH, Kim D, Lee H, Zheng H-M, Park BH, et al. Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells. Cancer Lett 2011; 306(2): 190-6.
Book:
[2] Minev BR. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures. 1st ed. Springer: New York 2011.
Book Chapter:
[3] Folkman J. Tumor Angiogenesis: From Bench to Bedside. In: Marmé D, Fusenig N, Eds. Tumor Angiogenesis: Basic Concepts and Cancer Therapy. 8thed. Berlin, Springer; 2008, pp. 3-28.
Conference Proceedings:
[4] Friedl P. Deep collective cancer invasion: Breaking radioresistance by anti-integrin therapy. 4th AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, Denver, CO, USA, September 27-30, 2010.
Meeting Abstract:
[5] Moss R, Bothos J, Filvaroff E, Merchant M, Eppler S, Yu W, et al. Phase Ib dose-escalation study of MetMAb, a monovalent antagonist antibody to the receptor MET, in combination with bevacizumab in patients with locally advanced or metastatic solid tumors. American Society of Clinical Oncology - 10th annual meeting, Chicago, USA (2010).
Website:
[6] Organogenesis company website. Available at:
http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html. (Accessed on: January 4, 2011)
Thesis:
[7] Lindh MB. Mechanisms determining efficacy of tyrosine kinase-targeting anti-cancer drugs. PhD thesis, Karolinska Institutet, Stockholm, Sweden, April 2011.
Patent:
[8] As a service, the Publishers can provide each author a certain number of relevant patents to assist them in writing their article. All patent application references will be provided by the author and will be published as it is.
Patent Reference Style:
All inventors' names of the patents must be stated with its title, publication number and the year of publication. For example: Prabhakar, B.S., Mulherkar, N. IG20 splice variants therapeutics for cancer. US7910723 (2011).
Citation of the patents will be according
to the international convention as follows:
• WO Patents: 1978-2003
Myers, C.E., Trepel, J., Sausville, E., Samid, D., Miller, A., Curt, G. Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer. WO9420080 (1994).
Nacht, M., Dracheva, T., Sidransky, D., Madden, S.L., Jen, J. Molecular characteristics of non-small cell lung cancer. WO03015613 (2003).
• WO Patents: 2004 onwards
Chan, P.-K., Mak, M.S. Inhibiting the invasion and metastasis of cancer cells. WO2011009032 (2011).
• US Patent Applications: 2001 onwards
Taylor, R.B., Henley, E.C. Composition for and method of preventing or treating breast cancer. US20010047033 (2001).
Yu, M. Compounds, composition, methods, targets for cancer therapy. US20110142815 (2011).
• Issued/Granted US Patents:
Sakamoto, I., Takagi, K. Anti-cancer device. US4536387 (1985).
Koya, K. Combination with bis(thiohydrazide amides) for treating cancer. US7939564 (2011).
• EP Patents:
Sakamoto, I., Takagi, K. Anti-cancer device. EP0086627 (1985).
Gevas, P.C., Karr, S.L., Grimes, S., Michaeli, D., Watson, S.A. Immunological methods for the treatment of gastrointestinal cancer. EP0889735 (2011).
Some important points to remember:
• Superscripts in the in-text citations and reference
section should be avoided.
• Abstracts, unpublished data and personal communications
(which can only be included if prior permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text and details provided as footnotes.
• The authors are encouraged to use a recent version
of EndNote (version 5 and above) or Reference Manager (version
10) when formatting their reference list, as this allows references
to be automatically extracted.
12. Tables:
• Data tables should be submitted in Microsoft Word
table format.
• Each table should include a title / caption being
explanatory in itself with respect to the details discussed
in the table. Detailed legends may then follow.
• Table number in bold font i.e. Table 1,
should follow a title. The title should be in small case with
the first letter in caps. A full stop should be placed at
the end of the title.
• Tables should be embedded in the text exactly according
to their appropriate placement in the submitted manuscript.
• Columns and rows of data should be made visibly distinct
by ensuring that the borders of each cell are displayed as
black lines.
• Tables should be numbered in Arabic numerals sequentially
in order of their citation in the body of the text.
• If a reference is cited in both the table and text,
please insert a lettered footnote in the table to refer to
the numbered reference in the text.
• Tabular data provided as additional files can be submitted
as an MS Excel spreadsheet.
13. Figures/illustrations: The
quality of the illustrations printed in the journal largely
depends on the quality of the figures / illustration provided
by the author. The acceptance of a manuscript for publication
is subject to the figures being up to the highest standards
in terms of clarity and resolution. In case, the figures supplied
are not up to the standards required, the authors will be
given the option to either return the manuscripts within one
week with appropriate drawings / figures or they may opt to
have these professionally prepared through the paid professional
service available from Bentham Publishing Services.
The authors should provide the illustrations
as separate files, as well as embedded in the text file, numbered
consecutively in the order of their appearance. Each figure
should include a single illustration. Each figure should be
closely cropped to minimize the amount of white space surrounding
the illustration. If a figure consists of separate parts,
it is important that a single composite illustration file
be submitted, containing all parts of the figure.
Photographs should be provided with a scale
bar if appropriate, as well as high-resolution component files.
Scaling/Resolution:
For Line Art image type, which is generally an image based on lines and text and does not contain tonal or shaded areas, the preferred file format is TIFF or EPS, with color mode being Monochrome 1-bit or RGB, in a resolution of 900-1200 dpi.
For Halftone image type, which is generally a continuous tone photograph and contains no text, the preferred file format is TIFF, with color mode being RGB or Grayscale, in a resolution of 300 dpi.
For Combination image type, which is generally an image containing halftone in addition to text or line art elements, the preferred file format is TIFF, with color mode being or RGB or Grayscale, in a resolution of 500-900 dpi.
Formats:
For illustrations, the following file formats are acceptable:
• Illustrator
• EPS (preferred format for diagrams)
• PDF (also especially suitable for diagrams)
• PNG (preferred format for photos or images)
• Microsoft Word (version 5 and above; figures must
be a single page)
• PowerPoint (figures must be a single page)
• TIFF
• JPEG (conversion should be done using the original
file)
• BMP
• CDX (ChemDraw)
• TGF (ISISDraw)
Bentham Science does not process
figures submitted in GIF format.
If the large size of TIFF or EPS figures
acts as an obstacle to online submission, authors may find
that conversion to JPEG format before submission results in
significantly reduced file size and upload time, while retaining
acceptable quality. JPEG is a 'lossy' format. However, in
order to maintain acceptable image quality, it is recommended
that JPEG files are saved at High or Maximum quality.
Files should not be compressed with tools such as Zipit or
Stuffit prior to submission as these tools will in any case
produce negligible file-size savings for JPEGs and TIFFs,
which are already compressed.
Please do not:
1. Supply embedded graphics in your word processor (spreadsheet,
presentation) document;
2. Supply files that are optimized for screen use (like GIF,
BMP, PICT, WPG); the resolution is too low;
3. Supply files that are too low in resolution;
4. Submit graphics that are disproportionately large for the
content.
Image Conversion Tools:
There are many software packages, many of them freeware or
shareware, capable of converting to and from different graphics
formats, including PNG.
Good general tools for image conversion include
GraphicConverter on the Macintosh, PaintShop Pro, for Windows,
and ImageMagick, which is available on Macintosh, Windows
and UNIX platforms.
Note that bitmap images (e.g. screenshots)
should not be converted to EPS, since this will result in
a much larger file size than the equivalent JPEG, TIFF, PNG
or BMP, with no increase in quality. EPS should only be used
for images produced by vector-drawing applications such as
Adobe Illustrator or CorelDraw. Most vector-drawing applications
can be saved in, or exported as, EPS format. In case the images
have been originally prepared in an Office application, such
as Word or PowerPoint, then the original Office files should
be directly uploaded to the site, instead of being converted
to JPEG or another format that may be of low quality.
Color Figures/Illustrations:
•The cost for the first published page of color figures is US$ 965; the second additional page will be for US$ 705 and each subsequent page for US$ 480.
Chemical Structures:
Chemical structures must be prepared in ChemDraw (CDX) and
provided as separate file.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120°
Bond spacing 18% of width
Fixed length 14.4
pt (0.500cm, 0.2in)
Bold width
2.0 pt (0.071cm, 0.0278in)
Line width 0.6
pt (0.021cm, 0.0084in)
Margin width 1.6 pt
(0.096cm)
Hash spacing 2.5 pt (0.088cm,
0.0347in)
Text Settings:
Font
Times New Roman
Size
8 pt
Under the Preference Choose:
Units
points
Tolerances 3
pixels
Under Page Setup Use:
Paper
US letter
Scale
100%
14. Supportive/Supplementary Material:
We do encourage to append supportive material, for example
a PowerPoint file containing a talk about the study, a PowerPoint
file containing additional screenshots, a Word, RTF, or PDF
document showing the original instrument(s) used, a video,
or the original data (SAS / SPSS files, Excel files, Access
Db files etc.) provided it is inevitable or endorsed
by the journal's Editor.
Supportive/Supplementary material intended for publication
must be numbered and referred to in the manuscript
but should not be a part of the submitted paper.
In-text citations as well as a section with the heading "Supportive
/ Supplementary Material" before the "References"
section should be provided. Here, list all Supportive / Supplementary
Material and include a brief caption line for each file describing
its contents.
Any additional files will be linked into
the final published article in the form supplied by the author,
but will not be displayed within the paper. They will be made
available in exactly the same form as originally provided
only on our website. Please also make sure
that each additional file is a single table, figure or movie
(please do not upload linked worksheets or PDF files larger
than one sheet). Supportive / Supplementary material must be
provided in a single zipped file not larger than 4
MB.
Authors must clearly indicate if these files
are not for publication but meant for the reviewers' / editors'
perusal only.
PERMISSION FOR REPRODUCTION:
Published / reproduced material should not be included unless
you have obtained written permission from the copyright holder,
which should be forwarded to the Editorial Office in case
of acceptance of your article for publication.
For obtaining permission of reproducing any
material published in an article by Bentham Science Publishers,
please fill in the request FORM
and send to patents@benthamscience.org
for consideration.
REVIEWING AND PROMPTNESS OF PUBLICATION:
All papers submitted for publication are immediately subjected
to editorial scrutiny, usually in consultation with members
of the journal Editorial Advisory Board and outside independent
reviewers. Every effort will be made to peer review submitted
papers quickly. Papers which are delayed by authors in revision
for more than 30 days will have to be re-submitted as a new
submission. Papers accepted for publication are typeset and
proofs are dispatched to authors for any corrections prior
to final publication.
QUICK TRACK Publication: For this journal
an optional fast publication fee-based service called QUICK
TRACK is available to authors for their submitted manuscripts.
QUICK TRACK allows online publication within 2 weeks of receipt
of the final approved galley proofs from the authors. Similarly
the manuscript can be published in the next forthcoming PRINT
issue of the journal. The total publication time, from date
of first receipt of manuscript to its online publication is
10 weeks, subject to its acceptance by the referees and modification
(if any) by the authors within one week.
Corresponding authors who opt for QUICK TRACKS will receive
25 free e-reprint tokens for their manuscripts.
For more information please contact the Editorial Office by
e-mail at patents@benthamscience.org.
PAGE CHARGES: No page charges will be levied
to the authors.
LANGUAGE EDITING: Manuscripts
submitted containing many English typographical errors will
not be published. Authors from non-English language countries
are advised to use the services of our professional language
editing department prior to submitting their manuscript to
the journal. Please contact Bentham Publishing
Services (www.benthampublishingservices.com)
for a language editing quote via e-mail at: info@benthampublishingservices.com
stating the total number of words of the article to be edited.
PROOFS: Authors will receive page proofs
of their accepted paper before publications. To avoid delays
in publication, proofs should be checked immediately for typographical
errors and returned within 48 hours. Major
changes are not acceptable at the proof stage. If unable to
send corrections within 48 hours due to some
reason, the author(s) must at least send an acknowledgement
on receiving the galley proofs or the article will be published
exactly as received and the publishers will not be responsible
for any error occurring in the published manuscript in this
regard.
The corresponding author will be solely responsible
for ensuring that the revised version of the manuscript incorporating
all the submitted corrections receives the approval of all
the co-authors of the manuscript.
REPRINTS: Each first-named (corresponding)
author will receive electronically five free eprints of their
published article. Printed reprints may be ordered from the
Publisher prior to publication of the article. First named
authors may also order a personal print and online subscription
of the journal at 50% off the normal subscription rate by
contacting the subscription department at e-mail: subscriptions@benthamscience.org
OPEN ACCESS PLUS: Accepted articles can be
published online for free open access for all to view, and
be deposited by the Publishers in PubMed Central. Open access
publishing provides the maximum dissemination of the article
to the largest audience. Authors must pay for this service.
All corresponding authors will be asked to indicate whether
or not they wish to pay to have their paper made freely available
on publication. If authors do not select the Open Access option,
then their article will be published with standard subscription-based
access at no charge.
Bentham Science offers authors the choice of open access publication
of their articles at a fee of US$ 2,900 per
published article which allows indefinite free-to-view online
publication with Bentham Science.
For more information please contact us at e-mail: openaccess@benthamscience.org.
FEATURED ARTICLE: Authors may opt to publicize their article(s) published with Bentham Science by highlighting their title(s) both at the journal's Homepage and the issue Contents page at a cost of US$ 600.
COPYRIGHT: Authors who publish
in Bentham Science Journals will transfer copyright
to their work to Bentham Science Publishers. Submission
of a manuscript to the respective journals implies that all
authors have read and agreed to the content of the Covering
Letter or the Terms and Conditions. It is a condition of publication
that manuscripts submitted to this journal have not been published
and will not be simultaneously submitted or published elsewhere.
Plagiarism is strictly forbidden, and by submitting the article
for publication the authors agree that the publishers have
the legal right to take appropriate action against the authors,
if plagiarism or fabricated information is discovered. By
submitting a manuscript the authors agree that the copyright
of their article is transferred to the publishers if and when
the article is accepted for publication. Once submitted to
the journal, the author will not withdraw their manuscript
at any stage prior to publication.
Plagiarism Prevention:
Bentham Science Publisher uses the iThenticate software to
detect instances of overlapping and similar text in submitted
manuscripts. iThenticate software checks content uploaded
by a journal editorial office against a database of periodicals,
the Internet, and a comprehensive article database. It generates
a similarity report, including the percentage overlap between
the uploaded article and published material. Any instances
of content overlap are treated according to a journal’s
peer review integrity statement and the policies recommended
by the editorial Committee. You are assured that the publisher,
where you are submitting your manuscript, is committed to
actively combating plagiarism and publishing original research.
E-PUB AHEAD OF SCHEDULE: Bentham Science
Publishers are pleased to offer electronic publication of
accepted papers prior to scheduled publication. These peer-reviewed
papers can be cited using the date of access and the unique
DOI number. Any final changes in manuscripts will be made
at the time of print publication and will be reflected in
the final electronic version of the issue. Articles ahead
of schedule may be ordered by pay-per-view at the relevant
links by each article stated via the E-Pub
Ahead of Schedule (http://www.benthamscience.com/pra/E-Pub-Ahead-of-Schedule.htm).
Disclaimer: Articles appearing in E-Pub Ahead-of-Schedule
sections have been peer-reviewed and accepted for publication
in this journal and posted online before scheduled publication.
Articles appearing here may contain statements, opinions,
and information that have errors in facts, figures, or interpretation.
Accordingly, Bentham Science Publishers, the editors
and authors and their respective employees are not responsible
or liable for the use of any such inaccurate or misleading
data, opinion or information contained of articles in the
E-Pub Ahead-of-Schedule.
|
